NCT07368062 Mental Health After Dexmedetomidine for Electrical Storm
| NCT ID | NCT07368062 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ottawa Heart Institute Research Corporation |
| Condition | Mental Health |
| Study Type | OBSERVATIONAL |
| Enrollment | 70 participants |
| Start Date | 2025-03-15 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 70 participants in total. It began in 2025-03-15 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of the research study is to measure mental health and quality of life indices of individuals treated for electrical storm (ES). The consequences of being admitted to an intensive care unit (ICU) with electrical storm as well as the treatments patients would have received, are currently not well understood. Understanding the mental health burden of these treatments among survivors can provide insights into how to improve care. This is a study consisting of patients who participated in the SEDATE trial (dexmedetomidine vs usual standard of care to treat ES in the ICU). Patients who consent to participate in this study will be asked to complete a set of questionnaires 3-6 months after their ICU admission. The purpose of the questionnaires is to measure indices of mental health and health-related quality of life. Each questionnaire will take about 5-15 minutes to complete. If patients have a scheduled follow-up at the University of Ottawa Heart Institute, a member of the research team will meet with them during their clinic visit to complete the questionnaires. Otherwise, they can be completed over the telephone.
Eligibility Criteria
Inclusion Criteria: * Patients admitted to an intensive care unit with a diagnosis of electrical storm within the preceding 6 months * Previous participants in the SEDATE trial (NCT06281977) Exclusion Criteria: \- None
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07368062 clinical trial?
This trial is open to participants of all sexes, studying Mental Health. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07368062 currently recruiting?
Yes, NCT07368062 is actively recruiting participants. Contact the research team at dramirez@ottawaheart.ca for enrollment information.
Where is the NCT07368062 trial being conducted?
This trial is being conducted at Ottawa, Canada.
Who is sponsoring the NCT07368062 clinical trial?
NCT07368062 is sponsored by Ottawa Heart Institute Research Corporation. The trial plans to enroll 70 participants.